FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2751614930> ?p ?o ?g. }

• W2751614930 abstract "Of the seven thousand diseases that are described as rare, 80% of them have an identified genetic cause. With this in the mind, the development of technologies, such as gene therapy, to address the genetic factors involved in these pathologies, might be a game-changing therapeutic approach. Viral delivery of transgenes for RNA interference, DNA editing, or protein overexpression may offer opportunities for novel treatments. In this thesis, we developed adeno-associated virus (AAV) vector systems to tackle two rare diseases: Amyotrophic lateral sclerosis (ALS) caused by gain-of-function mutations in the superoxide dismutase 1 (SOD1) gene and inherited hearing loss disorder caused by mutation in the transmembrane channel-like 1 (TMC1) gene. ALS is a fatal neurodegenerative disease caused by the progressive degeneration of motoneurons (MN). Glial cells have been shown to importantly contribute to the disease. Silencing of the human pathogenic mutated SOD1 protein (SOD1G93A) in MN and/or astrocytes by AAV-mediated expression of microRNA targeting SOD1 has been shown to provide therapeutic benefits in a mouse model which is overexpressing SOD1G93A. However, in order to have an effective treatment, it is important to understand the influence of the therapy on several relevant ALS cell types. In this work, we determined the effects of lowering SOD1G93A expression in astrocytes using an AAV serotype 9, in combination with an astrocyte-specific promoter, in order to express a microRNA targeting SOD1. In the treated mice, we observed a significant improvement of the neuromuscular function and a partial protection of the vulnerable fast-fatigable MN. SOD1 silencing also induced a significant re-innervation of the neuromuscular junctions (NMJ) in the gastrocnemius muscle, observed after the initial phase of denervation, occurring around the age of 60 days. Re-innervation was associated with a grouping of the muscle fibers from the same type, consistent with enhanced axonal plasticity in the treated SOD1G93A mice. Overall, we demonstrated that silencing of SOD1 in astrocytes has an impact on MN plasticity at the level of NMJ, which translates into improved neuromuscular function towards the end stage of the disease. Mutations in the TMC1 gene lead to either complete deafness at birth, or to progressive hearing loss beginning in childhood, depending on the mode of inheritance (autosomal recessive or dominant, respectively). TMC1 is likely a component of the mechanotransduction channel, which is responsible for the transformation of mechanical sound-induced stimuli into electrical signals. This protein has been found to be expressed in the stereociliae of hair cells. In the second part of the thesis, we report on the development of viral tools to deliver a functional copy of the TMC1 gene, or its related paralog TMC2, into hair cells. We engineered several AAV vectors, in combination with different promoters, to identify a suitable combination able to restore TMC expression in the mouse cochlear hair cells, both in vitro and in vivo. We demonstrated, in collaboration with the lab of J. Holt, that when injected in TMC-null mice at birth, these vectors could partially restore loss of auditory function in this mouse model otherwise completely deaf. Overall we showed that AAV-based gene therapy is a promising approach to treat rare genetic disease." @default.
• W2751614930 created "2017-09-15" @default.
• W2751614930 creator A5074420172 @default.
• W2751614930 date "2017-01-01" @default.
• W2751614930 modified "2023-09-23" @default.
• W2751614930 title "AAV based gene therapy for rare diseases" @default.
• W2751614930 doi "https://doi.org/10.5075/epfl-thesis-7888" @default.
• W2751614930 hasPublicationYear "2017" @default.
• W2751614930 type Work @default.
• W2751614930 sameAs 2751614930 @default.
• W2751614930 citedByCount "0" @default.
• W2751614930 crossrefType "journal-article" @default.
• W2751614930 hasAuthorship W2751614930A5074420172 @default.
• W2751614930 hasConcept C102230213 @default.
• W2751614930 hasConcept C104317684 @default.
• W2751614930 hasConcept C111599444 @default.
• W2751614930 hasConcept C119056186 @default.
• W2751614930 hasConcept C142724271 @default.
• W2751614930 hasConcept C145059251 @default.
• W2751614930 hasConcept C166703698 @default.
• W2751614930 hasConcept C2777615887 @default.
• W2751614930 hasConcept C2778107364 @default.
• W2751614930 hasConcept C2779134260 @default.
• W2751614930 hasConcept C2780596555 @default.
• W2751614930 hasConcept C40767141 @default.
• W2751614930 hasConcept C502942594 @default.
• W2751614930 hasConcept C54355233 @default.
• W2751614930 hasConcept C60644358 @default.
• W2751614930 hasConcept C67705224 @default.
• W2751614930 hasConcept C71924100 @default.
• W2751614930 hasConcept C86803240 @default.
• W2751614930 hasConcept C92087593 @default.
• W2751614930 hasConceptScore W2751614930C102230213 @default.
• W2751614930 hasConceptScore W2751614930C104317684 @default.
• W2751614930 hasConceptScore W2751614930C111599444 @default.
• W2751614930 hasConceptScore W2751614930C119056186 @default.
• W2751614930 hasConceptScore W2751614930C142724271 @default.
• W2751614930 hasConceptScore W2751614930C145059251 @default.
• W2751614930 hasConceptScore W2751614930C166703698 @default.
• W2751614930 hasConceptScore W2751614930C2777615887 @default.
• W2751614930 hasConceptScore W2751614930C2778107364 @default.
• W2751614930 hasConceptScore W2751614930C2779134260 @default.
• W2751614930 hasConceptScore W2751614930C2780596555 @default.
• W2751614930 hasConceptScore W2751614930C40767141 @default.
• W2751614930 hasConceptScore W2751614930C502942594 @default.
• W2751614930 hasConceptScore W2751614930C54355233 @default.
• W2751614930 hasConceptScore W2751614930C60644358 @default.
• W2751614930 hasConceptScore W2751614930C67705224 @default.
• W2751614930 hasConceptScore W2751614930C71924100 @default.
• W2751614930 hasConceptScore W2751614930C86803240 @default.
• W2751614930 hasConceptScore W2751614930C92087593 @default.
• W2751614930 hasLocation W27516149301 @default.
• W2751614930 hasOpenAccess W2751614930 @default.
• W2751614930 hasPrimaryLocation W27516149301 @default.
• W2751614930 hasRelatedWork W115647664 @default.
• W2751614930 hasRelatedWork W1979837223 @default.
• W2751614930 hasRelatedWork W1991316383 @default.
• W2751614930 hasRelatedWork W1994439489 @default.
• W2751614930 hasRelatedWork W2021421724 @default.
• W2751614930 hasRelatedWork W2035397639 @default.
• W2751614930 hasRelatedWork W2044678926 @default.
• W2751614930 hasRelatedWork W2050946454 @default.
• W2751614930 hasRelatedWork W2070243481 @default.
• W2751614930 hasRelatedWork W2078818999 @default.
• W2751614930 hasRelatedWork W2114142555 @default.
• W2751614930 hasRelatedWork W2124976615 @default.
• W2751614930 hasRelatedWork W2141759311 @default.
• W2751614930 hasRelatedWork W2157890177 @default.
• W2751614930 hasRelatedWork W2213197090 @default.
• W2751614930 hasRelatedWork W2469721505 @default.
• W2751614930 hasRelatedWork W2777540887 @default.
• W2751614930 hasRelatedWork W3119323736 @default.
• W2751614930 hasRelatedWork W2135691971 @default.
• W2751614930 hasRelatedWork W2513788247 @default.
• W2751614930 isParatext "false" @default.
• W2751614930 isRetracted "false" @default.
• W2751614930 magId "2751614930" @default.
• W2751614930 workType "article" @default.